Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJ NYSE:MRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$192.31-0.3%$181.99$140.68▼$194.48$463.53B0.48.73 million shs8.88 million shsMRKMerck & Co., Inc.$87.25-0.4%$84.37$73.31▼$106.62$218.83B0.3712.64 million shs7.68 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson-0.26%+0.27%+9.05%+14.27%+15.95%MRKMerck & Co., Inc.-0.41%+4.21%+9.21%+2.86%-17.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$192.31-0.3%$181.99$140.68▼$194.48$463.53B0.48.73 million shs8.88 million shsMRKMerck & Co., Inc.$87.25-0.4%$84.37$73.31▼$106.62$218.83B0.3712.64 million shs7.68 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson-0.26%+0.27%+9.05%+14.27%+15.95%MRKMerck & Co., Inc.-0.41%+4.21%+9.21%+2.86%-17.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.77Moderate Buy$199.053.51% UpsideMRKMerck & Co., Inc. 2.30Hold$104.3319.59% UpsideCurrent Analyst Ratings BreakdownLatest MRK and JNJ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/22/2025JNJJohnson & JohnsonJohnson RiceSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform ➝ Hold$190.0010/22/2025JNJJohnson & JohnsonLoop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$190.0010/20/2025JNJJohnson & JohnsonDaiwa AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy10/20/2025JNJJohnson & JohnsonDaiwa Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Outperform$203.0010/16/2025JNJJohnson & JohnsonHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$210.00 ➝ $215.0010/15/2025JNJJohnson & JohnsonArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$210.0010/15/2025JNJJohnson & JohnsonRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$174.00 ➝ $209.0010/15/2025JNJJohnson & JohnsonMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$190.0010/15/2025JNJJohnson & JohnsonStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$165.00 ➝ $190.0010/15/2025JNJJohnson & JohnsonCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$213.00 ➝ $215.0010/13/2025MRKMerck & Co., Inc.CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$84.00 ➝ $95.00(Data available from 10/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$92.15B5.03$13.08 per share14.70$29.69 per share6.48MRKMerck & Co., Inc.$64.17B3.40$9.42 per share9.26$18.33 per share4.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$10.3618.5617.372.2727.26%33.08%13.30%N/AMRKMerck & Co., Inc.$17.12B$6.4913.448.810.9625.79%41.05%16.55%10/30/2025 (Estimated)Latest MRK and JNJ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/30/2025Q3 2025MRKMerck & Co., Inc.$2.37N/AN/AN/A$17.00 billionN/A10/14/2025Q3 2025JNJJohnson & Johnson$2.76$2.80+$0.04$2.12$23.73 billion$23.99 billion7/29/2025Q2 2025MRKMerck & Co., Inc.$2.03$2.13+$0.10$1.76$15.92 billion$15.81 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.202.70%N/A50.19%64 YearsMRKMerck & Co., Inc.$3.243.71%N/A49.92%14 YearsLatest MRK and JNJ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/14/2025JNJJohnson & Johnsonquarterly$1.302.72%11/25/202511/25/202512/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.501.010.76MRKMerck & Co., Inc.0.691.421.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%MRKMerck & Co., Inc.76.07%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%MRKMerck & Co., Inc.0.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,1002.41 billion2.40 billionOptionableMRKMerck & Co., Inc.75,0002.50 billion2.49 billionOptionableMRK and JNJ HeadlinesRecent News About These CompaniesBleakley Financial Group LLC Has $5.52 Million Stock Position in Merck & Co., Inc. $MRK1 hour ago | marketbeat.comMerck & Co., Inc. $MRK Shares Sold by Brookstone Capital Management2 hours ago | marketbeat.com5 Best Dividend Stocks in the S&P 500October 23 at 12:06 PM | 247wallst.comeschbach's Shiftconnector® Helps Power Merck's Visual Factory to Drive Greater Transparency, Agility, and Supply Chain ResilienceOctober 23 at 11:55 AM | prnewswire.comMerck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseOctober 23 at 11:06 AM | zacks.comStrata Wealth Advisors LLC Takes Position in Merck & Co., Inc. $MRKOctober 23 at 10:07 AM | marketbeat.comFSM Wealth Advisors LLC Acquires 4,003 Shares of Merck & Co., Inc. $MRKOctober 23 at 9:57 AM | marketbeat.comMerck Keytruda formulations undergo FDA priority review for bladder cancerOctober 23 at 9:46 AM | msn.comFirst Citizens Bank & Trust Co. Sells 17,254 Shares of Merck & Co., Inc. $MRKOctober 23 at 9:30 AM | marketbeat.comLoring Wolcott & Coolidge Fiduciary Advisors LLP MA Sells 14,614 Shares of Merck & Co., Inc. $MRKOctober 23 at 9:06 AM | marketbeat.comClifford Swan Investment Counsel LLC Sells 2,872 Shares of Merck & Co., Inc. $MRKOctober 23 at 8:02 AM | marketbeat.comRNC Capital Management LLC Reduces Stock Holdings in Merck & Co., Inc. $MRKOctober 23 at 7:38 AM | marketbeat.comFreedom Investment Management Inc. Grows Stock Holdings in Merck & Co., Inc. $MRKOctober 23 at 7:37 AM | marketbeat.comForum Financial Management LP Sells 4,413 Shares of Merck & Co., Inc. $MRKOctober 23 at 7:23 AM | marketbeat.comCaliber Wealth Management LLC KS Decreases Stake in Merck & Co., Inc. $MRKOctober 23 at 7:13 AM | marketbeat.comMerck & Co., Inc. (MRK) Projected to Post Quarterly Earnings on ThursdayOctober 23 at 5:04 AM | marketbeat.comMerck & Co Unusual Options ActivityOctober 22 at 6:42 PM | benzinga.comEthic Inc. Buys 8,003 Shares of Merck & Co., Inc. $MRKOctober 22 at 9:38 AM | marketbeat.comBirch Hill Investment Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRKOctober 22 at 8:42 AM | marketbeat.comSteel Grove Capital Advisors LLC Raises Stock Holdings in Merck & Co., Inc. $MRKOctober 22 at 8:19 AM | marketbeat.comFamily Capital Management Inc. Buys 5,122 Shares of Merck & Co., Inc. $MRKOctober 22 at 7:56 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Why AbbVie and Johnson & Johnson Could Outperform PfizerBy Chris Markoch | October 8, 2025Johnson & Johnson Stock Can Keep Rising as Strategy Pays OffBy Thomas Hughes | October 15, 2025Johnson & Johnson's M&A Strategy Is the Real Story for InvestorsBy Jeffrey Neal Johnson | October 18, 2025MRK and JNJ Company DescriptionsJohnson & Johnson NYSE:JNJ$192.31 -0.63 (-0.33%) Closing price 10/23/2025 03:59 PM EasternExtended Trading$192.44 +0.14 (+0.07%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.Merck & Co., Inc. NYSE:MRK$87.25 -0.36 (-0.42%) Closing price 10/23/2025 03:59 PM EasternExtended Trading$87.22 -0.02 (-0.02%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Is Oracle’s AI Rally Over? Wall Street Thinks ORCL Could Hit $400 GM Posts Largest Gain Since the Pandemic: Shares Still Look Cheap 3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
